CAS RN: 1333145-89-3
Varenicline Impurity 3
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1333145-89-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
1333145-89-3 / 6-methyl-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene
Standard CAS: 1333145-89-3
Multi CAS: No
Basic Information
copy
CAS
1333145-89-3 copy
Multi CAS
No copy
Molecular Formula
C14H15N3 copy
Molecular Weight
225.290000 copy
Exact Mass
225.126597 copy
SMILES
CC1=CN=C2C=C3C4CC(C3=CC2=N1)CNC4 copy
InChI
InChI=1S/C14H15N3/c1-8-5-16-13-3-11-9-2-10(7-15-6-9)12(11)4-14(13)17-8/h3-5,9-10,15H,2,6-7H2,1H3 copy
InChIKey
SYUMLVIBVORUHM-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
17 copy
Aromatic heavy atom count
10 copy
Fraction Csp3
0.43 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
67.24 copy
TPSA
37.81 copy
LogP / Solubility
WLOGP
2.11 copy
MLOGP
1.86 copy
XLogP3
1.2 copy
Consensus LogP
1.72 copy
Log S (ESOL)
-3 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-2.93 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.88 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.59 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
5 copy